Europe Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Type (Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin), By Country and Growth Forecast, 2022 - 2028

Europe Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Type (Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin), By Country and Growth Forecast, 2022 - 2028

The Europe Blood Plasma Derivatives Market would witness market growth of 9.1% CAGR during the forecast period (2022-2028).

Plasma, or blood plasma, is the liquid component of blood. Plasma functions as a transport medium for providing nutrients to the cells of the different organs of the body and for transferring metabolic waste products to the liver, kidneys, and lungs for elimination. It is also a blood cell transport mechanism and plays a crucial function in maintaining appropriate blood pressure.

Plasma helps maintain homeostasis, also called biological stability, including the acid-base balance within the blood and organism. Blood cells, including white blood cells (leukocytes), red blood cells (erythrocytes), and platelets (thrombocytes), are isolated from whole blood to produce plasma. The residual straw-colored fluid comprises a significant amount of water, but it also includes essential solutes required for life. Electrolytes, like sodium, potassium, magnesium, bicarbonate, and calcium are important ingredients.

In addition, traces of amino acids, organic acids, vitamins, pigments, and enzymes are present. The endocrine system secretes hormones such as corticosteroids, insulin, and thyroxine into the blood. Hormone plasma concentrations must be carefully managed for optimal health. With renal failure, the amount of nitrogenous wastes (such as urea and creatinine) delivered to the kidney for excretion increases significantly.

The increasing government, as well as international support in the European countries in order to improve plasma research and uses, would accelerate the growth of the blood plasma derivatives market in the region. FDA has MRAs in place with the European Union and the United Kingdom. Since 2014, the FDA and the EU have partnered to study how each authority inspects drug producers and the risks and advantages of mutual recognition of drug inspections. The increasing focus of government along with various public organizations would drive the growth of the regional market.

The Germany market dominated the Europe Blood Plasma Derivatives Market by Country in 2021; thereby, achieving a market value of $4,815.1 Million by 2028. The UK market is exhibiting a CAGR of 8.2% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 9.9% during (2022 - 2028).

Based on Application, the market is segmented into Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia, Von Willebrand's Disease, and Others. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Immunodeficiency Diseases
  • Hypogammaglobulinemia
  • Hemophilia
  • Von Willebrand's Disease
  • Others
By End User
  • Hospitals
  • Clinics
  • Others
By Type
  • Immunoglobulin
  • Albumin
  • Factor VIII
  • Factor IX
  • Hyperimmune Globulin
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Bayer AG
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • Biotest AG
  • LFB S.A.
  • CSL Limited
  • Octapharma AG
  • Kedrion S.p.A
  • Sanofi S.A.
  • Fusion Health Care Pvt. Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Blood Plasma Derivatives Market, by Application
1.4.2 Europe Blood Plasma Derivatives Market, by End User
1.4.3 Europe Blood Plasma Derivatives Market, by Type
1.4.4 Europe Blood Plasma Derivatives Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Blood Plasma Derivatives Market
Chapter 4. Europe Blood Plasma Derivatives Market by Application
4.1 Europe Immunodeficiency Diseases Market by Country
4.2 Europe Hypogammaglobulinemia Market by Country
4.3 Europe Hemophilia Market by Country
4.4 Europe Von Willebrand's Disease Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Blood Plasma Derivatives Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Clinics Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Blood Plasma Derivatives Market by Type
6.1 Europe Immunoglobulin Market by Country
6.2 Europe Albumin Market by Country
6.3 Europe Factor VIII Market by Country
6.4 Europe Factor IX Market by Country
6.5 Europe Hyperimmune Globulin Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Blood Plasma Derivatives Market by Country
7.1 Germany Blood Plasma Derivatives Market
7.1.1 Germany Blood Plasma Derivatives Market by Application
7.1.2 Germany Blood Plasma Derivatives Market by End User
7.1.3 Germany Blood Plasma Derivatives Market by Type
7.2 UK Blood Plasma Derivatives Market
7.2.1 UK Blood Plasma Derivatives Market by Application
7.2.2 UK Blood Plasma Derivatives Market by End User
7.2.3 UK Blood Plasma Derivatives Market by Type
7.3 France Blood Plasma Derivatives Market
7.3.1 France Blood Plasma Derivatives Market by Application
7.3.2 France Blood Plasma Derivatives Market by End User
7.3.3 France Blood Plasma Derivatives Market by Type
7.4 Russia Blood Plasma Derivatives Market
7.4.1 Russia Blood Plasma Derivatives Market by Application
7.4.2 Russia Blood Plasma Derivatives Market by End User
7.4.3 Russia Blood Plasma Derivatives Market by Type
7.5 Spain Blood Plasma Derivatives Market
7.5.1 Spain Blood Plasma Derivatives Market by Application
7.5.2 Spain Blood Plasma Derivatives Market by End User
7.5.3 Spain Blood Plasma Derivatives Market by Type
7.6 Italy Blood Plasma Derivatives Market
7.6.1 Italy Blood Plasma Derivatives Market by Application
7.6.2 Italy Blood Plasma Derivatives Market by End User
7.6.3 Italy Blood Plasma Derivatives Market by Type
7.7 Rest of Europe Blood Plasma Derivatives Market
7.7.1 Rest of Europe Blood Plasma Derivatives Market by Application
7.7.2 Rest of Europe Blood Plasma Derivatives Market by End User
7.7.3 Rest of Europe Blood Plasma Derivatives Market by Type
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Grifols, S.A
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Biotest AG (Tiancheng International Investment Limited)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 LFB S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 CSL Limited (CSL Behring)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Octapharma AG
8.7.1 Company Overview
8.8 Kedrion S.p.A
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fusion Health Care Pvt. Ltd.
8.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings